Abbreviated Study Title |
Type of Study |
P.I.(s) |
RT/Temodar/cpt-11 for GBM |
RTOG Phase II |
Curran |
Whole breast vs. partial breast RT for Breast CA |
RTOG/NSABP Phase III |
Anne/Rudoler |
Neoadjuvant chemo-RT for rectal CA |
RTOG Phase IIR |
Anne |
High dose vs. moderate dose RT for prostate CA |
RTOG Phase III |
Valicenti |
Postop RT + chemo + C-225 for head/neck CA |
RTOG Phase IIR |
Machtay |
RT + chemo + C-225 for inoperable lung CA |
RTOG Phase II |
Werner-Wasik |
Prophylactic brain irradiation for lung CA |
RTOG Phase III |
Werner-Wasik |
|
|
|
ABC Breath-hold irradiation for Left-sided breast Cancer* |
Investigator-initiated Phase II |
Anne |
RT + hormones + Samarium radioisotope therapy for Prostate Cancer. |
Investigator-initiated Phase I |
Valicenti |
RT + Epothilone radiosensitizing chemo for CNS or head and neck Cancer. |
Investigator-initiated Phase I |
Dicker |
RT +Capecitabine + cpt-11 multimodality therapy for rectal cancer. |
Investigator-initiated Phase I |
Anne |
Randomized trial of Immobilization for CNS Image Guided Radiation Therapy (Stereotactic RT). |
Investigator-initiated Phase III |
Bednarz/Machtay |
Stereotactic irradiation + Gefitinib for inoperable lung cancer. |
Investigator-initiated Phase I |
Werner-Wasik |
|
|
|
RT +/- Temodar for Brain metastases from lung cancer. |
Corporate (Schering) Phase III |
Curran |
Benzydamine for prevention of RT mucositis for patients with head and neck cancer.* |
Corporate (McNeil) Phase III |
Machtay |